A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor

Cancer immunotherapy has recently drawn remarkable attention as promising results in the clinic have shown its ability to improve the overall survival, and T cells are considered to be one of the primary effectors for cancer immunotherapy. Enhanced and restored T cell tumoricidal activity has shown...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:AAPS J
Autores principales: Ma, Huilin, Wang, Hanwen, Sove, Richard J., Jafarnejad, Mohammad, Tsai, Chia-Hung, Wang, Jun, Giragossian, Craig, Popel, Aleksander S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7293198/
https://ncbi.nlm.nih.gov/pubmed/32533270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-020-00450-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares